BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Santantonio TA, Fasano M. Chronic hepatitis B: Advances in treatment. World J Hepatol 2014; 6(5): 284-292 [PMID: 24868322 DOI: 10.4254/wjh.v6.i5.284]
URL: https://www.wjgnet.com/1948-5182/full/v6/i5/284.htm
Number Citing Articles
1
Antje Blank, Christoph Markert, Nicolas Hohmann, Alexandra Carls, Gerd Mikus, Thorsten Lehr, Alexander Alexandrov, Mathias Haag, Matthias Schwab, Stephan Urban, Walter E. Haefeli. First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex BJournal of Hepatology 2016; 65(3): 483 doi: 10.1016/j.jhep.2016.04.013
2
Maheeba Abdulla, Mohamed Ghuloom, Hafsa Nass, Nafeesa Mohammed, Eman Farid, Jehad ALQamish. Prevalence of hepatitis B e antigenemia in Bahraini hepatitis B patients: A retrospective, single‐center studyJGH Open 2021; 5(3): 337 doi: 10.1002/jgh3.12494
3
Guo Qing Yin, Bei Zhong. Efficacy of interferon for chronic hepatitis B in patients with nucleoside and nucleotide combination therapy failureJournal of Gastroenterology and Hepatology 2016; 31(1): 248 doi: 10.1111/jgh.13191
4
Waled Mohsen, Miriam T. Levy. Hepatitis A to E: what's new?Internal Medicine Journal 2017; 47(4): 380 doi: 10.1111/imj.13386
5
Abdullah Ely, Prashika Singh, Tiffany S. Smith, Patrick Arbuthnot. In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infectionAdvanced Drug Delivery Reviews 2021; 168: 134 doi: 10.1016/j.addr.2020.05.010
6
Michael R. Charlton, Altaf Alam, Akash Shukla, Bekhbold Dashtseren, Cosmas Rinaldi Adithya Lesmana, Davadoorj Duger, Diana Alcantara Payawal, Do Duy Cuong, Ganbolor Jargalsaikhan, Ian Homer Yee Cua, Jose Decena Sollano, Karam Romeo Singh, Kaushal Madan, Khin Maung Win, Khin Pyone Kyi, Kyaw Soe Tun, Mohd. Salih, Mukul Rastogi, Neeraj Saraf, Pham Thi Thu Thuy, Pham Tran Dieu Hien, Rino Alvani Gani, Rosmawati Mohamed, Tawesak Tanwandee, Teerha Piratvisuth, Wattana Sukeepaisarnjaroen, Win Naing, Zahid Yasin Hashmi. An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in AsiaJournal of Gastroenterology 2020; 55(9): 811 doi: 10.1007/s00535-020-01698-4
7
Jia-Li Wang, Xin-Fang Du, Shao-Long Chen, Yi-Qi Yu, Jing Wang, Xi-Qi Hu, Ling-Yun Shao, Jia-Zhen Chen, Xin-Hua Weng, Wen-Hong Zhang. Histological outcome for chronic hepatitis B patients treated with entecavir <italic>vs</italic> lamivudine-based therapyWorld Journal of Gastroenterology 2015; 21(32): 9598-9606 doi: 10.3748/wjg.v21.i32.9598
8
Yang Ke, Lin Wang, Le-Qun Li, Jian-Hong Zhong. Nucleos(t)ide analogues to treat hepatitis B virus-related hepatocellular carcinoma after radical resectionWorld Journal of Hepatology 2014; 6(9): 652-659 doi: 10.4254/wjh.v6.i9.652
9
Mi Na Kim, Ju Ho Lee, Young Eun Chon, Yeonjung Ha, Seong Gyu Hwang. Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsyEuropean Journal of Gastroenterology & Hepatology 2020; 32(3): 433 doi: 10.1097/MEG.0000000000001520
10
Giordano Madeddu, Silvia Ortu, Giovanni Garrucciu, Ivana Maida, Michela Melis, Alberto Augusto Muredda, Maria Stella Mura, Sergio Babudieri. DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapyJournal of Medical Virology 2017; 89(7): 1208 doi: 10.1002/jmv.24742
11
Seyed Moayed Alavian, Alireza Showraki. Hepatitis B and its Relationship With Oxidative StressHepatitis Monthly 2016; 16(9) doi: 10.5812/hepatmon.37973
12
R. Orlando, M. Foggia, A. E. Maraolo, S. Mascolo, G. Palmiero, O. Tambaro, G. Tosone. Prevention of hepatitis B virus infection: from the past to the futureEuropean Journal of Clinical Microbiology & Infectious Diseases 2015; 34(6): 1059 doi: 10.1007/s10096-015-2341-x
13
Jeong Han Kim, Ji Wan Kim, Jung Woong Seo, Won Hyeok Choe, So Young Kwon. Noninvasive Tests for Fibrosis Predict 5-Year Mortality and Hepatocellular Carcinoma in Patients With Chronic Hepatitis BJournal of Clinical Gastroenterology 2016; 50(10): 882 doi: 10.1097/MCG.0000000000000574
14
Lei Jiang, Xiaohua Wu, Fang He, Ying Liu, Xiaoqing Hu, Shunichi Takeda, Yong Qing, Michael R Volkert. Genetic Evidence for Genotoxic Effect of Entecavir, an Anti-Hepatitis B Virus Nucleotide AnalogPLOS ONE 2016; 11(1): e0147440 doi: 10.1371/journal.pone.0147440
15
Sheiliza Carmali, Hironobu Murata, Chad Cummings, Krzysztof Matyjaszewski, Alan J. Russell. NanoArmoring of Enzymes: Rational Design of Polymer-Wrapped EnzymesMethods in Enzymology 2017; 590: 347 doi: 10.1016/bs.mie.2016.12.005
16
Jia-Horng Kao, Tarik Asselah, Xiao-Guang Dou, Kamal Hamed. Telbivudine therapy for chronic hepatitis B: A journey to identify super-responders and to optimize treatment using the roadmap modelJournal of Gastroenterology and Hepatology 2017; 32(1): 73 doi: 10.1111/jgh.13512
17
Maren Gebbing, Thorsten Bergmann, Eric Schulz, Anja Ehrhardt. Gene therapeutic approaches to inhibit hepatitis B virus replicationWorld Journal of Hepatology 2015; 7(2): 150-164 doi: 10.4254/wjh.v7.i2.150
18
Marco Canzoni, Massimo Marignani, Maria Laura Sorgi, Paola Begini, Michela Ileen Biondo, Sara Caporuscio, Vincenzo Colonna, Francesca Della Casa, Paola Conigliaro, Cinzia Marrese, Eleonora Celletti, Irene Modesto, Mario Stefano Peragallo, Bruno Laganà, Andrea Picchianti-Diamanti, Roberta Di Rosa, Claudia Ferlito, Simonetta Salemi, Raffaele D’Amelio, Tommaso Stroffolini. Prevalence of Hepatitis B Virus Markers in Patients with Autoimmune Inflammatory Rheumatic Diseases in ItalyMicroorganisms 2020; 8(11): 1792 doi: 10.3390/microorganisms8111792